Pfizer-Astellas Alliance Grant for Independent Medical Education on Urothelial Cancer

Deadline: 06-Sep-2026 Astellas and Pfizer are inviting eligible organizations to apply for independent medical education grants addressing evolving treatment options for locally advanced/metastatic urothelial carcinoma (la/mUC) and muscle invasive bladder cancer (MIBC). Individual projects may request US$10,000 to US$150,000, with a total programme budget of US$450,000, to support healthcare professional education outside the United States.... [Read More] The post Pfizer-Astellas Alliance Grant for Independent Medical Education on Urothelial Cancer first appeared on fundsforNGOs.

Eligible applicants are organizations involved in healthcare professional education or healthcare improvement. These may include: Medical professional schools. Nursing professional schools. Allied health professional schools. Pharmacy professional schools. Healthcare institutions. Professional organizations. Medical societies. Medical education companies. The applicant organization should have a mission or organizational purpose related to healthcare professional education or improvement.